Copyright © Mend Therapeutics 2013
CONTACT US
Website designed by
Mend Therapeutics' Pipeline

MEND aims to create novel, first-in-class therapeutics and devices for the treatment of diabetic complications. Our first therapeutics MT-003, currently in Preclinical Development, is for the treatment of chronic diabetic foot wounds.
Our Solutions >>  Our Pipeline >>  MT-003  >> Future Vision >> Drug Development
We will work with academic, pharmaceutical, and other medical reseach partners to support basic medical research and help identify additional promising drug candidates and devices for the treatment of diabetic complications.
A Non-Profit Pharmaceutical Company
Compassionate Medicine For All
 
Stay Connected